The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.
Open Access
- 1 March 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (5) , 1795-1798
- https://doi.org/10.1073/pnas.89.5.1795
Abstract
The retinoblastoma-susceptibility gene product (RB) undergoes cell cycle-dependent phosphorylation and dephosphorylation. We characterized RB phosphorylation after mitogenic stimulation of primary human T lymphocytes, initially arrested in the G0 state. RB is phosphorylated in at least three steps when T cells are driven into the cell cycle. The first event occurs during mid G1 phase, the second during S phase, and the third in G2/M. Tryptic phosphopeptide mapping indicates that the different phosphorylation events occur, at least in part, on different residues in RB. Given the known relationship of the RB phosphorylation state to function, it is possible that RB regulates growth at multiple points in the cell cycle.Keywords
This publication has 23 references indexed in Scilit:
- The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2FCell, 1991
- Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factorNature, 1991
- Failure to Phosphorylate the Retinoblastoma Gene Product in Senescent Human FibroblastsScience, 1990
- The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large TCell, 1990
- In vitro phosphorylation of the tumor suppressor gene RB protein by mitosis-specific histone H1 kinaseBiochemical and Biophysical Research Communications, 1989
- The retinoblastoma protein is phosphorylated during specific phases of the cell cycleCell, 1989
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiationCell, 1989
- Contingent Genetic Regulatory Events in T Lymphocyte ActivationScience, 1989
- A monoclonal antibody blocking human T cell functionEuropean Journal of Immunology, 1980